Page last updated: 2024-08-26

nicotine and n,n'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine

nicotine has been researched along with n,n'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cryan, JF; Kaupmann, K; Lhuillier, L; Mombereau, C1

Other Studies

1 other study(ies) available for nicotine and n,n'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine

ArticleYear
GABAB receptor-positive modulation-induced blockade of the rewarding properties of nicotine is associated with a reduction in nucleus accumbens DeltaFosB accumulation.
    The Journal of pharmacology and experimental therapeutics, 2007, Volume: 321, Issue:1

    Topics: Animals; Blotting, Western; Conditioning, Operant; Cyclopentanes; GABA Modulators; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Proto-Oncogene Proteins c-fos; Pyrimidines; Rats; Rats, Wistar; Receptors, GABA-B; Reinforcement, Psychology; Reward

2007